US outpatient medtech payments under government scrutiny
This article was originally published in Clinica
Executive Summary
US government auditors have begun to scrutinise how well hospitals are complying with Medicare rules for the transitional pass-through payments under the outpatient prospective payment system (OPPS). That system allows hospitals to be reimbursed a special pass-through payment for certain new drugs, biologicals and medical devices.